Doug Klein

Dr. Doug Klein

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009
Verified
Journal Article
Closed access
DKDoug Klein
Doug Klein
MHMarianna Hofmeister
Marianna Hofmeister
JLJocelyn Lockyear
Jocelyn Lockyear
RCRodney Crutcher
Rodney Crutcher
HFHerta Fidler
Herta Fidler

31 August 2018 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
JKJennifer Klein
Jennifer Klein
PBPaula Brauer
Paula Brauer
DRDawna Royall
Dawna Royall
MIMaya Israeloff-Smith
Maya Israeloff-Smith
DKDoug Klein
Doug Klein
KJKhursheed Jeejeebhoy
Khursheed Jeejeebhoy
Patient perspectives on new programs to manage metabolic syndrome (MetS) are critical to evaluate for possible implementation in the primary healthcare system. Participants’ perspectives were sought for the Canadian Health Advanced by Nutrition and Graded Exercise (CHANGE) study, which enrolled 293 participants, and demonstrated 19% reversal of MetS after 1 year. The main purpose of this study was to examine participants’ perceptions of their experiences with the CHANGE program, enablers and barriers to change. A convergent parallel mixed methods design combined patients’ perspectives collected by questionnaires (n = 164), with insights from focus groups (n = 41) from three sites across Canada. Qualitative data were thematically analyzed using interpretative description. Insights were organized within a socio-ecologic framework. Key aspects identified by participants included intra-individual factors (personal agency, increased time availability), inter-individual factors (trust, social aspects) and organizational factors (increased mental health support, tailored programs). Results revealed participants’ overall support for the CHANGE program, especially the importance of an extended program under the guidance of a family physician along with a skilled and supportive team. Team delivery of a lifestyle program in primary care or family medicine clinics is a complex intervention and use of a mixed methods design was helpful for exploring patient experiences and key issues on enablers and barriers to health behavior change.

14 September 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
Elisa Marin-CoutureElisa Marin-Couture
Elisa Marin-Couture
MFMarie-Josée Filion
Marie-Josée Filion
RBRyma Boukari
Ryma Boukari
KJKhursheed Jeejeebhoy
Khursheed Jeejeebhoy
RDRupinder Dhaliwal
Rupinder Dhaliwal
Caroline RheaumeCaroline Rheaume
Caroline Rheaume
Systemic hypertension has been recognized as a modifiable traditional cardiovascular risk factor and influenced by many factors such as eating habits, physical activity, diabetes, and obesity. The objective of this cross-sectional study was to identify factors that predict changes in blood pressure induced by a one-year lifestyle intervention in primary care settings involving a collaboration between family physicians, dietitians, and exercise specialists. Patients with metabolic syndrome diagnosis were recruited by family physicians participating in primary care lifestyle intervention among several family care clinics across Canada. Participants for whom all cardiometabolic data at the beginning (T0) and the end (T12) of the one-year intervention were available were included in the present analysis (n = 101). Patients visited the dietitian and the exercise specialist weekly for the first three months and monthly for the last nine months. Diet quality, exercise capacity, anthropometric indicators, and cardiometabolic variables were evaluated at T0 and at T12. The intervention induced a statistically significant decrease in waist circumference (WC), systolic (SBP) and diastolic (DBP) blood pressure, and plasma triglycerides, and an increase in cardiorespiratory fitness (estimated VO2max). Body weight (p < 0.001), body mass index (BMI) (p < 0.001), and fasting blood glucose (p = 0.006) reduction, and VO2max increase (p = 0.048) were all related to changes in SBP. WC was the only variable for which changes were significantly correlated with those in both SBP (p < 0.0001) and DBP (p = 0.0004). Variations in DBP were not associated with changes in other cardiometabolic variables to a statistically significant extent. Twelve participants were identified as adverse responders (AR) in both SBP and DBP and displayed less favorable changes in WC. The beneficial effects of the primary care lifestyle intervention on blood pressure were significantly associated with cardiometabolic variables, especially WC. These findings suggest that a structured lifestyle intervention in primary care can help improve cardiometabolic risk factors in patients with metabolic syndrome and that WC should be systematically measured to better stratify the patient’s hypertension risk.

1 February 2008
Verified
Journal Article
Closed access
DKDoug Klein
Doug Klein
SSShirley Schipper
Shirley Schipper

1 January 2009 in Journal of Continuing Education in the Health Professions
Verified
Journal Article
Closed access
DKDoug Klein
Doug Klein
MAMichael G. Allan
Michael G. Allan
DMDonna Manca
Donna Manca
JSJoan Sargeant
Joan Sargeant
CBCarly Barnett
Carly Barnett

11 July 2006 in Family Practice
Verified
Journal Article
Open access
PDF file
DKDoug Klein
Doug Klein
AMA MacDonald
A MacDonald
NDN Drummond
N Drummond
ACA Cave
A Cave
Introduction. Cyclo-oxygenase-2 inhibiting (COXIB) anti-inflammatories have been the drug class prescribed for a large number of cases of musculoskeletal (MSK) disorders in Canada over the past 5 years. The Alberta Improvements for MSK Disorders (AIMS) initiative sought to better understand the COXIB prescribing situation by funding several studies. The objective of this qualitative study was to determine the factors underlying primary care physicians' medication prescribing behaviour during an office visit for an MSK disorder, with particular emphasis on the prescribing of COXIBs. Methods. The target respondents were Alberta primary care physicians chosen from a stratified random sample to meet a wide range of characteristics. Individual, semi-structured interviews were used to assess decision pathways in four real cases chosen by the physician. A total of 19 interviews were conducted and analysed using an analytic inductive approach. Results. Factors judged as being important to decision pathways in relation to COXIB prescribing for MSK disease included safety, patient characteristics, affordability to patients, availability of samples, drug company marketing practices, habit formation, time contstraints, previous clinical experience of doctors and/or patient with certain drugs and doctors' perception of absolute versus relative risk. Interpretation. Most physicians preferentially prescribed COXIBs subsequent to a complicated, multifactorial, but essentially patient-centred, decision-making process.